Perioperative Concerns for Transplant Recipients Undergoing Nontransplant Surgery

Surgical Clinics of North America

Volumn 86, Issue 5, 2006, Pages 1185-1194

  Whiting, James ^a  

^a MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADRENAL SUPPRESSION; BILE COMPOSITION; BILIARY TRACT DISEASE; CANCER; CARDIOVASCULAR RISK; CHOLECYSTECTOMY; CHOLECYSTITIS; CHOLELITHIASIS; CHOLESTASIS; DEEP VEIN THROMBOSIS; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; EMERGENCY SURGERY; GALLSTONE; GASTROINTESTINAL SURGERY; GRAFT REJECTION; HUMAN; HYPOTENSION; INCISIONAL HERNIA; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; LIVER TRANSPLANTATION; MALNUTRITION; MEDICAL EXAMINATION; MENTAL DISEASE; PANCREATITIS; PERIOPERATIVE PERIOD; PREMEDICATION; PRIORITY JOURNAL; RECIPIENT; REVIEW; SIDE EFFECT; SURGICAL INFECTION; VENOUS THROMBOEMBOLISM; WOUND COMPLICATION; WOUND HEALING IMPAIRMENT;

HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION;

EID: 33748127493     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2006.06.011     Document Type: Review

References (65)

1. Annual Report of the USRDS. Percentages and counts of reported ESRD patients: by treatment modality (2006), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. Kasiske B.L., Guijarro C., Massy Z.A., et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7 (1996) 158-165
3. Auerbach A.D., and Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 287 (2002) 1435-1444
4. McGory M.L., Maggard M.A., and Ko C.Y. A meta-analysis of perioperative beta blockade: what is the actual risk reduction?. Surgery 138 (2005) 171-179
5. Bratzler D.W., and Houck P.M. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 189 (2005) 395-404
6. Bratzler D.W., Houck P.M., Richards C., et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 140 (2005) 174-182
7. Kehlet H. A rational approach to dosage and preparation of parenteral glucocorticoid substitution therapy during surgical procedures. A short review. Acta Anaesthesiol Scand 19 (1975) 260-264
8. Brown C.J., and Buie W.D. Perioperative stress dose steroids: do they make a difference?. J Am Coll Surg 193 (2001) 678-686
9. Bromberg J.S., Baliga P., Cofer J.B., et al. Stress steroids are not required for patients receiving a renal allograft and undergoing operation. J Am Coll Surg 180 (1995) 532-536
10. Salem M., Tainsh Jr. R.E., Bromberg J., et al. Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg 219 (1994) 416-425
11. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 338S-400S
12. Hilbrands L.B., Demacker P.N., Hoitsma A.J., et al. The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients. J Am Soc Nephrol 5 (1995) 2073-2081
13. Cao S., Cox K., So S.S., et al. Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients. Dig Dis Sci 42 (1997) 1409-1415
14. Moran D., De Buitrago J.M., Fernandez E., et al. Inhibition of biliary glutathione secretion by cyclosporine A in the rat: possible mechanisms and role in the cholestasis induced by the drug. J Hepatol 29 (1998) 68-77
15. Hulzebos C.V., Bijleveld C.M., Stellaard F., et al. Cyclosporine A-induced reduction of bile salt synthesis associated with increased plasma lipids in children after liver transplantation. Liver Transpl 10 (2004) 872-880
16. Sutherland F.R., Preshaw R.M., and Shaffer E.A. The effect of cyclosporine and liver autotransplantation on bile flow and composition in dogs. Transplantation 55 (1993) 237-242
17. Chan F.K., and Shaffer E.A. Cholestatic effects of cyclosporine in the rat. Transplantation 63 (1997) 1574-1578
18. Kao L.S., Kuhr C.S., and Flum D.R. Should cholecystectomy be performed for asymptomatic cholelithiasis in transplant patients?. J Am Coll Surg 197 (2003) 302-312
19. Alberu J., Gatica M., Cachafeiro-Vilar M., et al. Asymptomatic gallstones and duration of cyclosporine use in kidney transplant recipients. Rev Invest Clin 53 (2001) 396-400
20. Spes C.H., Angermann C.E., Beyer R.W., et al. Increased incidence of cholelithiasis in heart transplant recipients receiving cyclosporine therapy. J Heart Transplant 9 (1990) 404-407
21. Weinstein S., Lipsitz E.C., Addonizio L., et al. Cholelithiasis in pediatric cardiac transplant patients on cyclosporine. J Pediatr Surg 30 (1995) 61-64
22. Jackson T., Treleaven D., Arlen D., et al. Management of asymptomatic cholelithiasis for patients awaiting renal transplantation. Surg Endosc 19 (2005) 510-513
23. Lord R.V., Ho S., Coleman M.J., et al. Cholecystectomy in cardiothoracic organ transplant recipients. Arch Surg 133 (1998) 73-79
24. Gracie W.A., and Ransohoff D.F. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 307 (1982) 798-800
25. Ransohoff D.F., and Gracie W.A. Treatment of gallstones. Ann Intern Med 119 (1993) 606-619
26. Friedman G.D. Natural history of asymptomatic and symptomatic gallstones. Am J Surg 165 (1993) 399-404
27. Bhatia D.S., Bowen J.C., Money S.R., et al. The incidence, morbidity, and mortality of surgical procedures after orthotopic heart transplantation. Ann Surg 225 (1997) 686-693
28. Graham S.M., Flowers J.L., Schweitzer E., et al. The utility of prophylactic laparoscopic cholecystectomy in transplant candidates. Am J Surg 169 (1995) 44-48
29. Melvin W.S., Meier D.J., Elkhammas E.A., et al. Prophylactic cholecystectomy is not indicated following renal transplantation. Am J Surg 175 (1998) 317-319
30. Peterseim D.S., Pappas T.N., Meyers C.H., et al. Management of biliary complications after heart transplantation. J Heart Lung Transplant 14 (1995) 623-631
31. Kao L.S., Flowers C., and Flum D.R. Prophylactic cholecystectomy in transplant patients: a decision analysis. J Gastrointest Surg 9 (2005) 965-972
32. Dean P.G., Lund W.J., Larson T.S., et al. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 77 (2004) 1555-1561
33. Humar A., Ramcharan T., Denny R., et al. Are wound complications after a kidney transplant more common with modern immunosuppression?. Transplantation 72 (2001) 1920-1923
34. Gomez R., Hidalgo M., Marques E., et al. Incidence and predisposing factors for incisional hernia in patients with liver transplantation. Hernia 5 (2001) 172-176
35. Troppmann C., Pierce J.L., Gandhi M.M., et al. Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. Transplantation 76 (2003) 426-429
36. Fishel R., Barbul A., Wasserkrug H.L., et al. Cyclosporine A impairs wound healing in rats. J Surg Res 34 (1983) 572-575
37. Mohacsi P.J., Tuller D., Hulliger B., et al. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor. J Heart Lung Transplant 16 (1997) 484-492
38. Petri J.B., Schurk S., Gebauer S., et al. Cyclosporine A delays wound healing and apoptosis and suppresses activin beta-A expression in rats. Eur J Dermatol 8 (1998) 104-113
39. Anstead G.M. Steroids, retinoids, and wound healing. Adv Wound Care 11 (1998) 277-285
40. Zeeh J., Inglin R., Baumann G., et al. Mycophenolate mofetil impairs healing of left-sided colon anastomoses. Transplantation 71 (2001) 1429-1435
41. Schaffer M., Fuchs N., Volker J., et al. Differential effect of tacrolimus on dermal and intestinal wound healing. J Invest Surg 18 (2005) 71-79
42. Sugerman H.J., Kellum Jr. J.M., Reines H.D., et al. Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg 171 (1996) 80-84
43. Sehgal S.N. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 31 (1998) 335-340
44. Kahan B.D. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet 356 (2000) 194-202
45. Gregory C.R., Huang X., Pratt R.E., et al. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 59 (1995) 655-661
46. Valente J.F., Hricik D., Weigel K., et al. Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant 3 (2003) 1128-1134
47. Langer R.M., and Kahan B.D. Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients. Transplantation 74 (2002) 804-808
48. Flechner S.M., Goldfarb D., Modlin C., et al. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 74 (2002) 1070-1076
49. Flechner S.M., Zhou L., Derweesh I., et al. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients. Transplantation 76 (2003) 1729-1734
50. Jolicoeur E.M., Qi S., Xu D., et al. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat. Transplantation 75 (2003) 54-59
51. Janssen H., Lange R., Erhard J., et al. Causative factors, surgical treatment and outcome of incisional hernia after liver transplantation. Br J Surg 89 (2002) 1049-1054
52. Mazzucchi E., Nahas W.C., Antonopoulos I., et al. Incisional hernia and its repair with polypropylene mesh in renal transplant recipients. J Urol 166 (2001) 816-819
53. Muller V., Lehner M., Klein P., et al. Incisional hernia repair after orthotopic liver transplantation: a technique employing an inlay/onlay polypropylene mesh. Langenbecks Arch Surg 388 (2003) 167-173
54. Antonopoulos I.M., Nahas W.C., Mazzucchi E., et al. Is polypropylene mesh safe and effective for repairing infected incisional hernia in renal transplant recipients?. Urology 66 (2005) 874-877
55. Catena F., Ansaloni L., Leone A., et al. Lichtenstein repair of inguinal hernia with Surgisis inguinal hernia matrix soft-tissue graft in immunodepressed patients. Hernia 9 (2005) 29-31
56. Steed D.L., Brown B., Reilly J.J., et al. General surgical complications in heart and heart-lung transplantation. Surgery 98 (1985) 739-745
57. Bardaxoglou E., Maddern G., Ruso L., et al. Gastrointestinal surgical emergencies following kidney transplantation. Transpl Int 6 (1993) 148-152
58. Smith P.C., Slaughter M.S., Petty M.G., et al. Abdominal complications after lung transplantation. J Heart Lung Transplant 14 (1995) 44-51
59. Maurer J.R. The spectrum of colonic complications in a lung transplant population. Ann Transplant 5 (2000) 54-57
60. Whiting J.F., and Hanto D.W. Cancer in recipients of organ allografts. In: Racusen L.C., Solez K., and Burdick J.F. (Eds). Kidney transplant rejection (1998), Marcel Dekker, New York 577-604
61. Buell J.F., Gross T.G., and Woodle E.S. Malignancy after transplantation. Transplantation 80 (2005) S254-S264
62. Humar A., Johnson E.M., Gillingham K.J., et al. Venous thromboembolic complications after kidney and kidney-pancreas transplantation: a multivariate analysis. Transplantation 65 (1998) 229-234
63. Abbott K.C., Cruess D.F., Agodoa L.Y., et al. Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States. Am J Kidney Dis 43 (2004) 120-130
64. Kazory A., Ducloux D., Coaquette A., et al. Cytomegalovirus-associated venous thromboembolism in renal transplant recipients: a report of 7 cases. Transplantation 77 (2004) 597-599
65. Jarrell B.E., Szentpetery S., Mendez-Picon G., et al. Greenfield filter in renal transplant patients. Arch Surg 116 (1981) 930-932